PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15882455-0	2005	ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines.	Cisplatin	71-80	ATP binding cassette subfamily C member 5	Homo sapiens	0-5	
15882455-0	2005	ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines.	Cisplatin	71-80	ERCC excision repair 2, TFIIH core complex helicase subunit	Homo sapiens	7-12	
15882455-0	2005	ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines.	Cisplatin	71-80	XPA, DNA damage recognition and repair factor	Homo sapiens	14-17	
15882455-0	2005	ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines.	Cisplatin	71-80	X-ray repair cross complementing 1	Homo sapiens	22-27	
15882455-2	2005	The purpose of this study was to determine whether transcript abundance (TA) levels of twelve selected DNA repair or multi-drug resistance genes (LIG1, ERCC2, ERCC3, DDIT3, ABCC1, ABCC4, ABCC5, ABCC10, GTF2H2, XPA, XPC and XRCC1) were associated with cisplatin chemoresistance and could therefore contribute to the development of a predictive marker.	Cisplatin	251-260	DNA ligase 1	Homo sapiens	146-150	
15882455-2	2005	The purpose of this study was to determine whether transcript abundance (TA) levels of twelve selected DNA repair or multi-drug resistance genes (LIG1, ERCC2, ERCC3, DDIT3, ABCC1, ABCC4, ABCC5, ABCC10, GTF2H2, XPA, XPC and XRCC1) were associated with cisplatin chemoresistance and could therefore contribute to the development of a predictive marker.	Cisplatin	251-260	ATP binding cassette subfamily C member 10	Homo sapiens	194-200